₹134.78
▲ +1.43 +1.07%
As of 09 Sept 2026 · delayed
NSE Listed
Zim Laboratories Limited (ZIMLAB)
Volume: 1,70,175Avg Vol 1W: 99,418.8Avg Vol 1M: 1,07,723.3552W Range:₹59.31₹144.49
Key Ratios
Checked 8h agoMarket Cap₹716 Cr
Current Price₹134.78
Previous Close₹133.35
High / Low (52w)₹144.49 / ₹59.31
Volume1,70,175
Avg Vol (1W)99,418.8
Avg Vol (1M)1,07,723.35
Stock P/E193.26
Book Value₹54.77
Dividend Yield0%
ROE197.1%
ROA68.6%
Revenue (TTM)₹386 Cr
Revenue Growth-1.2%
Profit Margin93.2%
Total Debt₹42 Cr
Shares Outstanding5 Cr
Face Value₹10
EPS (TTM)₹0.69
P/B2.43
Debt / Equity0.45
50 DMA₹118.74
200 DMA₹92.55
Day change+1.07%
Price Chart
₹134.78▲ 79.85% · 1Y
2025-09-102026-09-09
20-day avg volume: 1.1L shares
Pros
- Healthy return on equity of 197.1%.
- Company is almost debt-free.
- Revenue grew 20% YoY.
- Net profit is growing year over year.
Cons
- Stock trades at a high P/E of 193.
Quarterly Results
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹92 Cr | ₹96 Cr | ₹109 Cr | ₹72 Cr | ₹89 Cr | ₹109 Cr | ₹105 Cr | ₹94 Cr |
| EBITDA | ₹6 Cr | ₹8 Cr | ₹11 Cr | ₹1 Cr | ₹3 Cr | ₹9 Cr | ₹8 Cr | ₹-2 Cr |
| Net Profit | ₹2 Cr | ₹4 Cr | ₹5 Cr | ₹-2 Cr | ₹0 Cr | ₹4 Cr | ₹4 Cr | ₹-4 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2025 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹385 Cr | ₹109 Cr | ₹71 Cr | ₹88 Cr | ₹108 Cr | ₹103 Cr | ₹386 Cr | ₹93 Cr |
| EBITDA | ₹29 Cr | ₹12 Cr | ₹1 Cr | ₹3 Cr | ₹9 Cr | ₹8 Cr | ₹21 Cr | ₹-2 Cr |
| Net Profit | ₹12 Cr | ₹5 Cr | ₹-2 Cr | ₹0 Cr | ₹4 Cr | ₹3 Cr | ₹6 Cr | ₹-4 Cr |
| EPS | 2.5 | — | — | — | — | — | 1.19 | — |
Balance Sheet
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹328 Cr | ₹325 Cr | ₹325 Cr | ₹342 Cr | ₹342 Cr | ₹447 Cr | ₹472 Cr | ₹539 Cr |
| Total Liabilities | ₹177 Cr | ₹171 Cr | ₹164 Cr | ₹166 Cr | ₹141 Cr | ₹208 Cr | ₹220 Cr | ₹243 Cr |
| Equity | ₹151 Cr | ₹154 Cr | ₹161 Cr | ₹176 Cr | ₹200 Cr | ₹239 Cr | ₹252 Cr | ₹296 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹36 Cr | ₹27 Cr | ₹33 Cr | ₹50 Cr | ₹45 Cr | ₹19 Cr | ₹40 Cr | ₹53 Cr |
| Investing | ₹-21 Cr | ₹-19 Cr | ₹-6 Cr | ₹-15 Cr | ₹-36 Cr | ₹-73 Cr | ₹-40 Cr | ₹-56 Cr |
| Financing | ₹-15 Cr | ₹-2 Cr | ₹-26 Cr | ₹-33 Cr | ₹1 Cr | ₹60 Cr | ₹-9 Cr | ₹28 Cr |
| Free Cash Flow | ₹36 Cr | ₹27 Cr | ₹33 Cr | ₹50 Cr | ₹45 Cr | ₹19 Cr | ₹40 Cr | ₹53 Cr |
Shareholding
Promoter 30.36% Institutions 1.36% Public 68.28%
Efficiency & Working Capital
ROCE5.1%
Interest Coverage1.4
Dividend Payout—
Debtor Days106 d
Inventory Days91 d
Payable Days71 d
Cash Conversion Cycle127 d
Working Capital Days198 d
Shareholding Details
As of 2026-06-30
Promoter30.4%
FII0%
DII1.3%
Institutions1.4%
Public68.3%
Promoter Pledge0%
No. of Shareholders14,510
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 33.3% | 33.3% | 33.3% | 33.3% | 33.3% | 33.3% | 33.3% | 33.3% | 33.3% | 33.3% | 30.3% | 30.4% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0.2% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0.1% | 0.1% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.1% | 1.3% |
| Public | 66.7% | 66.7% | 66.7% | 66.6% | 66.6% | 66.3% | 66.5% | 66.5% | 66.5% | 66.5% | 69.6% | 68.3% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 15,305 | 17,342 | 17,100 | 17,483 | 17,716 | 17,450 | 17,448 | 16,641 | 17,282 | 17,251 | 16,636 | 14,510 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Anwar Siraj Daud | Shareholding of Promoter and Promoter Group | 25.1% | 1.34 Cr |
| Elimath Advisors Private Limited | Public Shareholding | 10.4% | 55,84,269 |
| Zakir S Vali | Public Shareholding | 9.4% | 50,47,420 |
| Florintree Trinex Llp | Public Shareholding | 8.9% | 47,64,497 |
| Sabbah Zulfiquar Kamal | Shareholding of Promoter and Promoter Group | 2.8% | 15,00,000 |
| Bonanza Business Services Pvt Ltd | Public Shareholding | 2.3% | 12,40,000 |
| Dr Iguer Abdelmounaim | Public Shareholding | 2.2% | 11,65,680 |
| Zulfiquar Kamal | Shareholding of Promoter and Promoter Group | 2.1% | 11,15,260 |
| Jyoti Bharat Sheth | Public Shareholding | 1.2% | 6,59,986 |
| Laadki Trading And Investments Limited | Public Shareholding | 1.2% | 6,59,263 |
| Tata India Pharma & Healthcare Fund | Public Shareholding | 1.1% | 5,71,629 |
| Hasan Kamal | Shareholding of Promoter and Promoter Group | 0.2% | 1,04,400 |
| Shabbar Siraj Daud | Shareholding of Promoter and Promoter Group | 0.1% | 42,000 |
| Farhat Shabbar Daud | Shareholding of Promoter and Promoter Group | 0.1% | 38,570 |
| Tasneem Anwar Daud | Shareholding of Promoter and Promoter Group | 0.1% | 30,000 |
| Shirin Siraj Daud | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Shakil Daud | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Salman Anwar Daud | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Lubna Daud | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Nazneen Hussain | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Nasir Murtaza Kamal | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Mustafa Kamal | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Seher Kamal | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Adamali Husain Firdosy | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Asefa Bano Adam Firdosy | Shareholding of Promoter and Promoter Group | 0% | 0 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Anwar Daud | Chairman & Non Executive Dir. | 2026 |
| Zulfiquar Kamal | ED / Whole Time Director / Promoter | 2026 |
| Niraj Dhadiwal | E D & Wholetime Director | 2026 |
| Prakash Sapkal | E D & Wholetime Director | 2026 |
| Kavita Loya | Independent Director | 2026 |
| Padmakar S. Joshi | Independent Director | 2026 |
| Kamlesh Shende | Independent Director | 2026 |
| Ashok Bhatia | Independent Director | 2026 |
| Piyush Nikhade | Company Sec. & Compli. Officer | 2026 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Pharmaceuticals | ₹0 Cr | — |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| In India | ₹59 Cr | 16% |
| Outside India | ₹311 Cr | 84% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹10 | 75 | 54 | 54 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-08-06 | Board Meetings | — |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2026 | 47 | 0 | 0 | 7 | 0 | 54 |
| 2026 | 1 | 0 | 0 | 0 | 0 | 1 |
| 2026 | 14 | 0 | 0 | 0 | 0 | 15 |
Substantial Acquisitions (SAST)
2 disclosure(s)
Market27/03/2024 · 11,70,860
Market07/11/2023 · 10,56,867
Company Information
Incorporated1984
ChairmanAnwar Daud
AuditorDeloitte Haskins & Sells LLP
Investor Email[email protected]
📍 Sadoday Gyan (Gr Floor), Opp NADT Nelson Square, Nagpur, Maharashtra, 440013
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Zenith Exports Ltd.Zenith Steel Pipes & Industries Ltd.Zensar Technologies Ltd.Zen Technologies LimitedZF Commercial Vehicle Control System India Ltd.Z F Steering Gear (India) Ltd.Zodiac Energy LimitedZodiac Clothing Company Ltd.Zota Health Care LimitedSaraswati Commercial (India) Ltd.Z-Tech India LimitedZuari Agro Chemicals Ltd.All “Z” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search